1. Home
  2. HCM vs PSNY Comparison

HCM vs PSNY Comparison

Compare HCM & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • PSNY
  • Stock Information
  • Founded
  • HCM 2000
  • PSNY 2017
  • Country
  • HCM Hong Kong
  • PSNY Sweden
  • Employees
  • HCM N/A
  • PSNY N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • PSNY Auto Manufacturing
  • Sector
  • HCM Health Care
  • PSNY Consumer Discretionary
  • Exchange
  • HCM Nasdaq
  • PSNY Nasdaq
  • Market Cap
  • HCM 2.6B
  • PSNY 2.3B
  • IPO Year
  • HCM N/A
  • PSNY N/A
  • Fundamental
  • Price
  • HCM $16.01
  • PSNY $0.91
  • Analyst Decision
  • HCM Sell
  • PSNY Hold
  • Analyst Count
  • HCM 1
  • PSNY 2
  • Target Price
  • HCM $13.75
  • PSNY $1.25
  • AVG Volume (30 Days)
  • HCM 56.9K
  • PSNY 3.3M
  • Earning Date
  • HCM 08-07-2025
  • PSNY 09-03-2025
  • Dividend Yield
  • HCM N/A
  • PSNY N/A
  • EPS Growth
  • HCM N/A
  • PSNY N/A
  • EPS
  • HCM 0.53
  • PSNY N/A
  • Revenue
  • HCM $602,197,000.00
  • PSNY $2,547,619,000.00
  • Revenue This Year
  • HCM N/A
  • PSNY $48.90
  • Revenue Next Year
  • HCM $15.49
  • PSNY $44.64
  • P/E Ratio
  • HCM $5.91
  • PSNY N/A
  • Revenue Growth
  • HCM N/A
  • PSNY 24.82
  • 52 Week Low
  • HCM $11.51
  • PSNY $0.84
  • 52 Week High
  • HCM $21.50
  • PSNY $1.68
  • Technical
  • Relative Strength Index (RSI)
  • HCM 48.16
  • PSNY 36.34
  • Support Level
  • HCM $17.19
  • PSNY $0.92
  • Resistance Level
  • HCM $16.35
  • PSNY $0.98
  • Average True Range (ATR)
  • HCM 0.29
  • PSNY 0.03
  • MACD
  • HCM -0.01
  • PSNY -0.00
  • Stochastic Oscillator
  • HCM 21.74
  • PSNY 0.73

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About PSNY Polestar Automotive Holding UK PLC ADS

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.

Share on Social Networks: